The price of Catalyst Biosciences Inc. (NASDAQ: CBIO) closed at $0.28 in the last session, down -2.23% from day before closing price of $0.29. In other words, the price has decreased by -$0.0065 from its previous closing price. On the day, 969946 shares were traded. CBIO stock price reached its highest trading level at $0.3080 during the session, while it also had its lowest trading level at $0.2715.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
We take a closer look at CBIO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 18.40 and its Current Ratio is at 18.40. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
On February 10, 2021, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $15.
On May 21, 2020, Raymond James started tracking the stock assigning a Outperform rating and target price of $20.Raymond James initiated its Outperform rating on May 21, 2020, with a $20 target price.
As of this moment, Catalyst’s Price-to-Earnings (P/E) ratio for their current fiscal year is 0.76. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.52 while its Price-to-Book (P/B) ratio in mrq is 0.31.
Stock Price History:
Over the past 52 weeks, CBIO has reached a high of $0.40, while it has fallen to a 52-week low of $0.06. The 50-Day Moving Average of the stock is 0.4596, while the 200-Day Moving Average is calculated to be 0.4378.
According to the various share statistics, CBIO traded on average about 1.07M shares per day over the past 3-months and 805.15k shares per day over the past 10 days. A total of 31.48M shares are outstanding, with a floating share count of 27.91M. Insiders hold about 0.10% of the company’s shares, while institutions hold 25.00% stake in the company. Shares short for CBIO as of Oct 13, 2022 were 531.45k with a Short Ratio of 0.43M, compared to 1.4M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 1.69% and a Short% of Float of 1.70%.
Dividends & Splits
The current Payout Ratio is 0.00% for CBIO, which recently paid a dividend on Jan 11, 2023 with an ex-dividend date of Sep 20, 2022. Stock splits for the company last occurred on Feb 12, 2017 when the company split stock in a 1:15 ratio.
The company has 1 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.1 for the current quarter, with a high estimate of -$0.1 and a low estimate of -$0.1, while EPS last year was -$0.8. The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.08 and low estimates of -$0.08.
Analysts are recommending an EPS of between $1 and $1 for the fiscal current year, implying an average EPS of $1. EPS for the following year is -$0.32, with 1 analysts recommending between -$0.32 and -$0.32.
A total of 1 analysts have provided revenue estimates for CBIO’s current fiscal year. The highest revenue estimate was $790k, while the lowest revenue estimate was $790k, resulting in an average revenue estimate of $790k. In the same quarter a year ago, actual revenue was $7.34M, down -89.20% from the average estimate.